Oncology & Cancer

Breast cancer recurrence risk lingers years after treatment ends

Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading, according to a new analysis from an international team of investigators ...

Oncology & Cancer

Daily texting effectively monitors Rx adherence, side effects

(HealthDay)—For patients with breast cancer receiving endocrine therapy, daily bidirectional text messaging can monitor adherence and adverse events (AEs), according to a study published online May 23 in JCO: Clinical Cancer ...

page 1 from 4